Rate this post

Willow vs Dr. House: Compare GLP-1 Programs & Pricing

Side-by-side Willow and Dr. House: semaglutide/tirzepatide starting prices, promos, membership rules, and official links.

Willow and Dr. House are two established telehealth providers offering GLP-1–based weight management programs. This article compares Willow vs Dr. House to help you identify which best fits your goals and preferences.

Visit Willow
Explore Dr. House

Willow vs Dr. House: Quick Overview

Provider	Semaglutide	Tirzepatide	Promo	Membership
Willow	$299.00	$399.00	Best for Oral and Injectable (Code: )	— No
Dr. House			(Code: )	— No

Willow vs Dr. House: Medical Process & Accessibility

Willow focuses on fast telehealth intake and clinician approval, while Dr. House provides structured follow‑ups and ongoing dose adjustments. Both platforms are fully virtual and partner with licensed U.S. pharmacies for compounded GLP‑1 prescriptions. All clinical decisions comply with FDA‑approved indications for weight management and diabetes.

Start with Willow

Willow vs Dr. House: Pricing Comparison

Willow starts semaglutide at $299.00 and tirzepatide at $399.00. Dr. House currently does not list publicly available starting prices on its website, making Willow the more transparent and lower‑cost option for patients who can compare side‑by‑side.

Both providers do not require a membership fee, and there are no hidden subscription charges. Willow’s promotional messaging highlights “Best for Oral and Injectable,” which may include a first‑month discount; Dr. House has not published a comparable promo at this time.

Compare Dr. House Pricing

Willow vs Dr. House: Clinical Oversight & Support

Both companies assign a board‑certified clinician to review each intake questionnaire, verify medical history, and approve the prescription. Willow’s streamlined workflow aims for approval within 24‑48 hours, whereas Dr. House emphasizes a more deliberate review process with optional video consultations for dose titration.

Book a Consultation with Willow

Willow vs Dr. House: Medication Quality & Safety

Compounded semaglutide and tirzepatide are manufactured in FDA‑registered pharmacies that follow United States Pharmacopeia (USP) standards. While these formulations are not the brand‑name Wegovy® or Mounjaro®, they contain the same active molecules and are prescribed by licensed clinicians under telehealth supervision, meeting all federal safety requirements.

Willow vs Dr. House: Customer Experience

Customer reviews frequently cite Willow’s affordability and rapid shipping (typically 5‑7 business days after prescription approval). Dr. House users often praise the thoroughness of follow‑up appointments and the personalized dose‑adjustment plans, though some note longer onboarding times.

Explore Dr. House Reviews

Willow vs Dr. House: Final Verdict

Choose Willow if you prioritize lower out‑of‑pocket cost, quick enrollment, and a straightforward pricing structure. Choose Dr. House if you value in‑depth clinical interaction, ongoing dose management, and are comfortable waiting for a more detailed intake process. Both platforms are legally compliant telehealth services that connect patients with qualified prescribers and U.S. pharmacies.

Join Willow
Get Started with Dr. House

Disclaimer

This article is for informational purposes only and does not constitute medical advice. ExploreProviders may receive affiliate commissions at no cost to you. Always consult a licensed clinician before beginning any medical treatment.

⭐ Editor’s Choice